Eleven new drugs for HIV representing 5 new categories of mechanism of action are now in various phases of clinical trials. Here's an overview.
Here’s a case in point about progressive multifocal leukoencephalopathy in a patient with long-standing HIV who had never taken HART.
In new guidelines, the WHO and CDC stress that women should not be denied access to progestin-only injectables. The CDC recommendations for other hormonal contraceptive methods remain unchanged.
Patients coinfected with HIV and HCV who drink at least 3 cups of coffee a day can cut their risk of dying in half, says a new study.
An intelligent risk stratification algorithm can trigger a prompt for clinicians to offer an HIV test when they are ordering routine blood tests, potentially leading to earlier HIV diagnoses.
Empowerment interventions for women living with HIV can help decrease acquisition of other sexually transmitted infections.
Starting ART on the same day a patient tests positive for HIV may confer significant benefits. Details here.
A new report from The National Academy of Sciences outlines specific actions you can take now to help reduce hepatitis B and C infections.
Antiretroviral drug regimens have been implicated as factors in the increased risk of coronary artery disease and myocardial infarction in those with HIV infection. Here: practical measures for prevention and screening.
Clinicians need to track not only current alcohol consumption among their HIV-infected patients—but also past use.
Antiretroviral therapy has dramatically reduced AIDS-associated morbidity and mortality -- but only in those who know they are HIV positive and if they maintain sustained engagement with care.
The paradigm of HIV care is changing for aging patients. This study sheds new light.
Turns out, older age may have its advantages when it comes to coping with HIV infection.